Combined intranasal nanoemulsion and RIG-I activating RNA adjuvants enhance mucosal, humoral, and cellular immunity to influenza virus

PT Wong, PH Goff, RJ Sun, MJ Ruge… - Molecular …, 2020 - ACS Publications
Current influenza virus vaccines are focused on humoral immunity and are limited by the
short duration of protection, narrow cross-strain efficacy, and suboptimal immunogenicity …
被引用次数：18 相关文章

Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.

PT Wong, PH Goff, RJ Sun, MJ Ruge… - Molecular …, 2020 - europepmc.org
Current influenza virus vaccines are focused on humoral immunity and are limited by the
short duration of protection, narrow cross-strain efficacy, and suboptimal immunogenicity …

Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus

PT Wong, PH Goff, RJ Sun, MJ Ruge… - Molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Current influenza virus vaccines are focused on humoral immunity and are limited by the
short duration of protection, narrow cross-strain efficacy, and suboptimal immunogenicity …